The therapeutic efficacy of propranolol in children with recurrent primary epistaxis

Bojko Bjelakovic1 Clinic of Pediatrics, Clinical Center, Nis, Serbia;2 Faculty of Medicine, University of Nis, Nis, SerbiaCorrespondence[email protected]

Mila Bojanovic2 Faculty of Medicine, University of Nis, Nis, Serbia;3 Clinic of Otorhinolaryngology, Clinical Center, Nis, Serbia

Stevo Lukic2 Faculty of Medicine, University of Nis, Nis, Serbia;4 Clinic of Neurology, Clinical Center, Nis, Serbia

Ljiljana Saranac1 Clinic of Pediatrics, Clinical Center, Nis, Serbia;2 Faculty of Medicine, University of Nis, Nis, Serbia

Vladislav Vukomanovic5 Mother and Child Health Institute, “Dr Vukan Cupic”, Belgrade, Serbia;6 Faculty of Medicine University of Belgrade, Serbia

Sergej Prijic5 Mother and Child Health Institute, “Dr Vukan Cupic”, Belgrade, Serbia

Nikola Zivkovic7 Institute of Pathology, Faculty of Medicine, University of Nis, Nis, Serbia

Dusica Randjelovic1 Clinic of Pediatrics, Clinical Center, Nis, Serbia

show all

The therapeutic efficacy of propranolol in children with recurrent primary epistaxis

Table 1 Clinical data of all children included in the study

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

The therapeutic efficacy of propranolol in children with recurrent primary epistaxis

Figures & data

Table 1 Clinical data of all children included in the study

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date